Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression
about
Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cellsHormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responsesEffects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neckChromatin-dependent cooperativity between site-specific transcription factors in vivoRegulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylationLigand-induced estrogen receptor alpha degradation by the proteasome: new actors?Regulation of peroxisome proliferator-activated receptor-alpha by MDM2.MDM2 gene SNP309 T/G and p53 gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European CaucasiansMDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism.Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in SingaporeMDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysisGenome wide transcriptional profiling in breast cancer cells reveals distinct changes in hormone receptor target genes and chromatin modifying enzymes after proteasome inhibition.Mechanisms and significance of nuclear receptor auto- and cross-regulation.Lysine 419 targets human glucocorticoid receptor for proteasomal degradation.A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferationGlucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancerRobust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 white nuclear families identified significant association and gene-gene interaction.Translational approaches targeting the p53 pathway for anti-cancer therapy.Proteasome activity modulates chromatin modifications and RNA polymerase II phosphorylation to enhance glucocorticoid receptor-mediated transcription.Glucocorticoid receptor expression in breast cancer associates with older patient ageLIN28A Modulates Splicing and Gene Expression Programs in Breast Cancer Cells.Mdm2 in growth signaling and cancer.Use of glucocorticoids and risk of breast cancer: a Danish population-based case-control study.Targeting the ubiquitin-proteasome pathway in breast cancer therapy.Early life adversity as a risk factor for visceral pain in later life: importance of sex differences.Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma.A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans.Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer.Impaired p53 function leads to centrosome amplification, acquired ERalpha phenotypic heterogeneity and distant metastases in breast cancer MCF-7 xenografts.CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteinsThe glucocorticoid receptor signalling in breast cancer.Estrogen receptor alpha (ERα/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer.Reprogramming the chromatin landscape: interplay of the estrogen and glucocorticoid receptors at the genomic level.Mdm2 deficiency suppresses MYCN-Driven neuroblastoma tumorigenesis in vivoEstrogen inhibits glucocorticoid action via protein phosphatase 5 (PP5)-mediated glucocorticoid receptor dephosphorylation.The Role of MDM2 Amplification and Overexpression in Tumorigenesis.TRIM25 has a dual function in the p53/Mdm2 circuit.Acute and chronic cadmium exposure promotes E-cadherin degradation in MCF7 breast cancer cells.Regulation of glucocorticoid receptor activity by a stress responsive transcriptional cofactor.Actin disruption inhibits endosomal traffic of P-glycoprotein-EGFP and resistance to daunorubicin accumulation.
P2860
Q24323720-7CDE3112-EEC9-4B8B-A402-CC14FC760BFBQ24613799-D6D4F879-C79E-48B3-AC0F-57B30A99B374Q24630090-F4FE4CDC-B72E-4D71-B34F-01635B444EF8Q24655323-9042E88B-D3D9-491F-A6EB-F1F7DAB3B241Q24793292-012DF526-072D-4D07-B6B0-2B7DB61E7E5CQ25257822-C3883561-E3BB-4971-955B-E932642DFF88Q29347007-2BD34712-8BD9-4314-801E-3CC2B5DE744EQ33330490-3AACDF65-1286-4EA8-9230-50305762FCADQ33373153-B09FEE9A-C3E6-4C74-A724-7472701538D8Q33539409-F043475F-6E2A-4805-B560-EBA61F66022DQ33643505-F81CE537-F369-4195-9C4C-19052F939BA2Q33825397-5F5FD4F8-52B5-4022-8D69-7A7BF0C38D67Q34026116-68BA3098-62D5-4729-9AA6-BCA297DED736Q34079754-EE0024E7-7B4D-4C8A-ABFD-F0EE5D2B4773Q35029505-E9A0A96F-CA32-4659-857F-37414C359048Q35631971-7A34495B-9E43-4E64-92FE-7F6BDC7DBE84Q35691699-098406BC-5083-48D0-80CB-D7F2D993E2D6Q35708113-F7D01BEB-C660-422D-8AC1-D659A4BF7789Q35948205-4483C701-B402-4ED4-9B59-36191ED91DDCQ35951359-BBA20D84-A589-49A8-80B4-A8EC541A9F9BQ35963802-C00C0BEF-F0CA-4E81-A5C6-7AF3B744AD71Q36294472-DEE02ACF-331D-4811-98AC-FDC82E9F24F9Q36393177-164A43AB-D7B3-4B07-9D7F-903F0A78847AQ36429691-EA4E83F1-9C61-4A33-B42B-D63928010998Q36605480-B57A131E-5DCF-4535-A768-941FFC6E6072Q36724434-16540338-57AE-4C57-9023-14B45FDA8BBAQ36745377-9037A2F7-BA8A-43B4-8E9D-42F56B9D9B3DQ36767278-03E49FD6-E52B-44F3-BDCC-A21426D15DF3Q36852947-E0DA4AF7-ADDA-4D00-8110-CDEC28BDB40CQ37021183-9AD2BA2D-D85D-41D5-A69C-1C6C4BC89C38Q37021452-4FE8BB10-D8C9-4582-A6D5-587C53878EAFQ37085951-38963804-549A-4F7B-A553-96F0DAACCC3FQ37237733-19126FBA-566B-4490-B604-5EDEA2DFE60EQ37268813-7B80A9A7-8B31-444B-9944-30A7868FFDBBQ37433415-243E2EB1-953A-4840-A9E4-CEAC6D47C7EFQ38837916-D7EC777C-ECBD-4240-833C-F3F80EF4FACDQ38904816-3CB668EF-69CF-4FC0-A87D-935C2A8EBF3CQ38998346-D079AE00-28F6-47B1-922F-4D170EA23E42Q39621513-FE6DD4BA-F6D6-4395-84C8-4C03E638DA3EQ40205149-81429A8C-9721-47A5-B76D-5A38CDA8F5E1
P2860
Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Estrogen receptor-dependent pr ...... ase in mdm2 protein expression
@ast
Estrogen receptor-dependent pr ...... ase in mdm2 protein expression
@en
type
label
Estrogen receptor-dependent pr ...... ase in mdm2 protein expression
@ast
Estrogen receptor-dependent pr ...... ase in mdm2 protein expression
@en
prefLabel
Estrogen receptor-dependent pr ...... ase in mdm2 protein expression
@ast
Estrogen receptor-dependent pr ...... ase in mdm2 protein expression
@en
P2860
P1476
Estrogen receptor-dependent pr ...... ase in mdm2 protein expression
@en
P2093
H Karimi Kinyamu
P2860
P304
P356
10.1128/MCB.23.16.5867-5881.2003
P407
P577
2003-08-01T00:00:00Z